STOCK TITAN

Warren Kanders' 28.9% Stake in Cadre (CDRE) Disclosed in 13G/A

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Cadre Holdings' Schedule 13G/A shows that Warren B. Kanders beneficially owns 11,823,511 shares of common stock, representing 28.9% of the class. The total includes 10,216,192 shares held by Kanders SAF, LLC (reported as 25%), 1,305,650 shares in a Roth IRA, 45,584 shares held personally, and 232,635 shares underlying options that are exercisable or exercisable within 60 days and therefore counted. The filing also discloses excluded awards: 229,797 options not currently exercisable and 2,071,481 restricted stock awards not vested or vesting within 60 days. Mr. Kanders is shown with sole voting and dispositive power over 11,800,061 shares and shared voting/dispositive power over 23,450 shares.

Positive

  • Material disclosure of ownership: Reporting of 11,823,511 shares (28.9%) provides transparency on insider concentration.
  • Clear breakdown: Filing specifies share sources including 10,216,192 shares held by Kanders SAF, LLC and 232,635 exercisable options included in the total.
  • Voting and dispositive power disclosed: Documents sole voting/dispositive power for 11,800,061 shares and shared power for 23,450 shares.

Negative

  • Excluded awards: 2,071,481 restricted stock awards and 229,797 options are excluded because they are not vested or exercisable, which limits immediate dilution clarity.
  • No statement of intent: The filing does not disclose any plans, proposals, or intentions regarding corporate actions or governance, leaving investor interpretation limited.

Insights

Significant disclosed stake but no actions or proposals stated; filing documents ownership composition.

The filing reports a material ownership position: 11.82 million shares (28.9%), including 10.22 million shares held by Kanders SAF, LLC. The statement breaks out exercisable options included in the count and larger option/restricted awards excluded as not currently exercisable or vested. The document provides clear voting and dispositive power figures but does not disclose any transaction, control intention, or plan to change governance. As a disclosure, it is material for holders monitoring insider concentration but contains no operational or corporate-action detail.

Ownership concentration is high; filing does not state any proposal to exert control or change governance.

The reported combined ownership indicates substantial concentration with a single beneficial owner and an affiliated entity holding a combined 28.9% of the outstanding common stock. The filing identifies which shares and options are included or excluded for the ownership calculation, clarifying the scope of immediate voting/dispositive power. No disclosures in this statement indicate plans, arrangements, or group formations to influence management or board composition, so governance implications remain observational rather than actionable based on this filing alone.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: Footnote to Rows 5, 7, and 9: Consists of (i) 45,584 shares held by Warren B. Kanders, (ii) 1,305,650 shares held by Warren B. Kanders Roth IRA, (iii) 10,216,192 shares held by Kanders SAF, LLC ("SAF"); and (iv) options to purchase an aggregate of 232,635 shares of Common Stock which were previously granted under the Company's 2021 Stock Incentive Plan and that are presently exercisable or exercisable within 60 days of June 30, 2025. Mr. Kanders is the sole member and manager of SAF, and accordingly all of the shares of the Company's common stock held by SAF may be deemed to be beneficially owned by Mr. Kanders. Footnote to Rows 6, 8 and 9: Consists of 23,450 shares held by Allison Kanders Roth IRA. Allison Kanders is the wife of Mr. Kanders, and accordingly all of the shares of the Company's common stock held by Allison Kanders may be deemed to be beneficially owned by Mr. Kanders. Footnote to Row 9: The amount reported above as being beneficially owned by Mr. Kanders (i) includes 232,635 shares underlying stock options to purchase shares of Common Stock which were previously granted under the Company's 2021 Stock Incentive Plan and that are presently exercisable or exercisable within 60 days of June 30, 2025; and (ii) excludes (a) 229,797 shares underlying stock options to purchase shares of Common Stock which were previously granted under the Company's 2021 Stock Incentive Plan and that are not presently exercisable or exercisable within 60 days of June 30, 2025; and (b) 2,071,481 shares underlying restricted Common Stock awards which were previously granted under the Company's 2021 Stock Incentive Plan and that are not presently vested or vesting within 60 days of June 30, 2025. Footnote to Row 11: The percentage of shares of Common Stock reported as being beneficially owned by Mr. Kanders is based upon 40,896,479 shares of Common Stock outstanding as of August 1, 2025, which includes: (i) 40,663,844 shares of Common Stock outstanding as of August 1, 2025, as set forth in the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 filed with the Securities and Exchange Commission on August 5, 2025; (ii) options to purchase an aggregate of 232,635 shares of Common Stock which were previously granted under the Company's 2021 Stock Incentive Plan and that are presently exercisable or exercisable within 60 days of June 30, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Note to Rows 5, 7 and 9: Mr. Kanders is the sole member and manager of SAF, and accordingly may be deemed to beneficially own all of the shares of the Company's common stock held by SAF. Note to Row 11: The percentage of shares of Common Stock reported as being beneficially owned by SAF is based upon 40,896,479 shares of Common Stock outstanding as of August 1, 2025, which includes: (i) 40,663,844 shares of Common Stock outstanding as of August 1, 2025, as set forth in the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 filed with the Securities and Exchange Commission on August 5, 2025; (ii) options to purchase an aggregate of 232,635 shares of Common Stock which were previously granted under the Company's 2021 Stock Incentive Plan and that are presently exercisable or exercisable within 60 days of June 30, 2025.


SCHEDULE 13G



Warren B. Kanders
Signature:/s/ Warren B. Kanders
Name/Title:Warren B Kanders
Date:08/12/2025
Kanders SAF, LLC
Signature:/s/ Warren B. Kanders
Name/Title:Warren B. Kanders / Manager
Date:08/12/2025

FAQ

How many CDRE shares does Warren B. Kanders beneficially own?

11,823,511 shares, representing 28.9% of the company's common stock as reported in the Schedule 13G/A.

What stake does Kanders SAF, LLC hold in CDRE?

10,216,192 shares, reported as 25% of the class and included in Mr. Kanders' beneficial ownership total.

Are any options or restricted awards included or excluded from the ownership total?

Included: 232,635 options exercisable or exercisable within 60 days are counted in the total. Excluded: 229,797 options not presently exercisable and 2,071,481 restricted stock awards not vested or vesting within 60 days.

What voting and dispositive powers are reported for Mr. Kanders?

Sole voting power: 11,800,061 shares; shared voting power: 23,450 shares. Sole dispositive power is 11,800,061 and shared dispositive power is 23,450.

What share count was used to calculate the ownership percentage for CDRE?

The percentage is based on a reported total of 40,896,479 shares of common stock outstanding used for the calculation.
Cadre Hldgs Inc

NYSE:CDRE

CDRE Rankings

CDRE Latest News

CDRE Latest SEC Filings

CDRE Stock Data

1.72B
29.04M
29.12%
69.63%
4.85%
Aerospace & Defense
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
JACKSONVILLE